Cornerstone Capital Management Holdings LLC. lessened its position in shares of Colgate-Palmolive (NYSE:CL) by 8.1% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 170,135 shares of the company’s stock after selling 14,997 shares during the quarter. Cornerstone Capital Management Holdings LLC.’s holdings in Colgate-Palmolive were worth $12,612,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in shares of Colgate-Palmolive by 2.4% in the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after purchasing an additional 1,621,392 shares during the period. Renaissance Technologies LLC grew its position in shares of Colgate-Palmolive by 42.4% in the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after purchasing an additional 2,903,800 shares during the period. First Eagle Investment Management LLC grew its position in shares of Colgate-Palmolive by 2.3% in the second quarter. First Eagle Investment Management LLC now owns 4,891,131 shares of the company’s stock valued at $362,580,000 after purchasing an additional 108,850 shares during the period. TIAA CREF Investment Management LLC grew its position in shares of Colgate-Palmolive by 3.7% in the second quarter. TIAA CREF Investment Management LLC now owns 4,725,042 shares of the company’s stock valued at $350,267,000 after purchasing an additional 170,053 shares during the period. Finally, Fiera Capital Corp grew its position in shares of Colgate-Palmolive by 17.3% in the second quarter. Fiera Capital Corp now owns 4,595,453 shares of the company’s stock valued at $340,662,000 after purchasing an additional 677,657 shares during the period. Institutional investors own 72.96% of the company’s stock.
Colgate-Palmolive (CL) opened at $73.04 on Monday. The firm has a market cap of $64,136.80, a PE ratio of 25.45, a P/E/G ratio of 3.34 and a beta of 0.81. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.27. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23.
The company also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date of this dividend was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total transaction of $660,690.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Stephen I. Sadove sold 20,780 shares of Colgate-Palmolive stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the transaction, the director now directly owns 36,268 shares in the company, valued at $2,557,619.36. The disclosure for this sale can be found here. Insiders have sold 173,673 shares of company stock worth $12,629,293 over the last ninety days. 1.02% of the stock is owned by insiders.
CL has been the topic of several research analyst reports. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 target price on the stock in a research report on Monday, September 25th. SunTrust Banks upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their target price for the company from $65.00 to $85.00 in a research report on Wednesday, October 11th. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Royal Bank Of Canada reiterated a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Finally, Jefferies Group restated a “hold” rating and set a $79.00 price target on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Two analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $76.04.
TRADEMARK VIOLATION NOTICE: This news story was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.com-unik.info/2017/12/04/cornerstone-capital-management-holdings-llc-has-12-61-million-position-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
What are top analysts saying about Colgate-Palmolive? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Colgate-Palmolive and related companies.